Cite
HARVARD Citation
Foureau, D. et al. (2021). Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma. Cancer medicine. pp. 6933-6936. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Foureau, D. et al. (2021). Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma. Cancer medicine. pp. 6933-6936. [Online].